Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
1.
Biotech Histochem ; 98(5): 360-371, 2023 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-37022146

RESUMEN

We evaluated the effects of prenatal and postnatal dietary zinc (Zn) deficiency or supplementation on mammary gland morphology and on acute response to 7,12-dimethylbenzanthracene (DMBA) in pubertal female rats. On gestational day 10 (GD 10), rat dams were allocated randomly into three experimental groups of 10: a Zn-adequate diet group (ZnA) fed 35 mg Zn/kg chow, a Zn-deficient diet group (ZnD) fed 3 mg ZN/kg chow and a Zn-supplemented diet group (ZnS) fed 180 mg Zn/kg chow. After weaning, female offspring were fed the same diet as their dams until postnatal day 53 (PND 53). All animals received a single 50 mg/kg dose of DMBA on PND 51 and were euthanized on PND 53. Female ZnD offspring exhibited significantly less weight gain compared to the ZnA group and reduced mammary gland development compared to the ZnD and ZnA groups. By PND 53, the Ki-67 labeling index in mammary gland epithelial cells was significantly greater for the ZnS group than for the ZnA and ZnD groups. Apoptosis and ER-α indices did not differ among groups. The ZnD group exhibited significantly increased lipid hydroperoxide (LOOH) levels and decreased catalase and glutathione peroxidase (GSH-Px) activity compared to the ZnA and ZnS groups. The ZnS group exhibited significantly reduced superoxide dismutase (SOD) activity compared to the ZnA and ZnS groups. We observed atypical ductal hyperplasia in the mammary gland of female ZnS group offspring compared to the ZnA and ZnD groups and decreased expression of the Api5 and Ercc1 genes related to apoptosis inhibition and DNA damage repair, respectively. Both the Zn-deficient and Zn-supplemented diet exerted adverse effects on offspring mammary gland morphology and acute response to DMBA.


Asunto(s)
9,10-Dimetil-1,2-benzantraceno , Dieta , Embarazo , Ratas , Femenino , Animales , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Apoptosis , Zinc/farmacología
2.
J Steroid Biochem Mol Biol ; 215: 106022, 2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-34774723

RESUMEN

Vitamin D3 (VD3) deficiency has been associated with increased risk for cirrhosis and hepatocellular carcinoma, a highly incident malignant neoplasia worldwide. On the other hand, VD3 supplementation has shown some beneficial effects in clinical studies and rodent models of chronic liver disease. However, preventive effects of dietary VD3 supplementation in cirrhosis-associated hepatocarcinogenesis is still unknow. To investigate this purpose, male Wistar rats submitted to a combined diethylnitrosamine- and thioacetamide-induced model were concomitantly supplemented with VD3 (5,000 and 10,000 IU/kg diet) for 25 weeks. Liver samples were collected for histological, biochemical and molecular analysis. Serum samples were used to measure 25-hydroxyvitamin D [25(OH)D] and alanine aminotransferase levels. Both VD3 interventions decreased hepatic collagen deposition and pro-inflammatory p65 protein levels, while increased hepatic antioxidant catalase and glutathione peroxidase activities and serum 25(OH)D, without a clear dose-response effect. Nonetheless, only the highest concentration of VD3 increased hepatic protein levels of VD receptor, while decreased the number of large preneoplastic glutathione-S-transferase- (>0.5 mm²) and keratin 8/18-positive lesions, as well the multiplicity of hepatocellular adenomas. Moreover, this intervention increased hepatic antioxidant Nrf2 protein levels and glutathione-S-transferase activity. In summary, dietary VD3 supplementation - in special the highest intervention - showed antifibrotic and antineoplastic properties in chemically-induced cirrhosis-associated hepatocarcinogenesis. The positive modulation of Nrf2 antioxidant axis may be mechanistically involved with these beneficial effects, and may guide future clinical studies.


Asunto(s)
Adenoma de Células Hepáticas/prevención & control , Carcinoma Hepatocelular/prevención & control , Suplementos Dietéticos , Cirrosis Hepática/tratamiento farmacológico , Neoplasias Hepáticas/prevención & control , Vitamina D/administración & dosificación , Adenoma de Células Hepáticas/inducido químicamente , Adenoma de Células Hepáticas/metabolismo , Adenoma de Células Hepáticas/patología , Alanina Transaminasa/sangre , Alanina Transaminasa/genética , Animales , Carcinoma Hepatocelular/inducido químicamente , Carcinoma Hepatocelular/metabolismo , Carcinoma Hepatocelular/patología , Catalasa/sangre , Catalasa/genética , Quimioprevención/métodos , Colágeno/genética , Colágeno/metabolismo , Dietilnitrosamina/toxicidad , Regulación de la Expresión Génica/efectos de los fármacos , Glutatión Peroxidasa/sangre , Glutatión Peroxidasa/genética , Glutatión Transferasa/genética , Glutatión Transferasa/metabolismo , Queratinas/genética , Queratinas/metabolismo , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Cirrosis Hepática/inducido químicamente , Cirrosis Hepática/metabolismo , Cirrosis Hepática/patología , Neoplasias Hepáticas/inducido químicamente , Neoplasias Hepáticas/metabolismo , Neoplasias Hepáticas/patología , Masculino , Factor 2 Relacionado con NF-E2/genética , Factor 2 Relacionado con NF-E2/metabolismo , Proteínas de Neoplasias/genética , Proteínas de Neoplasias/metabolismo , Proteínas de Transporte Nucleocitoplasmático/genética , Proteínas de Transporte Nucleocitoplasmático/metabolismo , Ratas , Ratas Wistar , Receptores de Calcitriol/genética , Receptores de Calcitriol/metabolismo , Tioacetamida/toxicidad , Vitamina D/análogos & derivados , Vitamina D/sangre
3.
Environ Toxicol ; 35(4): 518-527, 2020 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-31804025

RESUMEN

Nonalcoholic steatohepatitis (NASH) is considered growing risk factor for hepatocellular carcinoma development in high-income countries. Diet- and chemically induced rodent models have been applied for the translational study of NASH-associated hepatocarcinogenesis due to their morphological and molecular similarities to the corresponding human disease. Arctium lappa L. (burdock) root tea has been extensively consumed in Traditional Chinese Medicine due to its potential therapeutic properties. Indeed, the bioactive compounds of A. lappa root, as the polyphenols, have already showed antioxidant and anti-inflammatory properties in different in vivo and in vitro bioassays. In this study, we investigated whether burdock root ethanolic extract (BRE) administration attenuates NASH-associated hepatocarcinogenesis. Eight-week-old male Wistar rats received choline-deficient high-fat diet for 8 weeks and multiple thioacetamide doses for 4 weeks in order to induce NASH and preneoplastic glutathione-S-transferase pi (GST-P)+ preneoplastic foci. Subsequently, rats were treated with BRE (100 or 200 mg/kg body weight) or vehicle by oral gavage for 2 weeks. BRE displayed high levels of chlorogenic and caffeic acids and BRE administration reduced total fatty acid and lipid hydroperoxide levels, while increasing the activities of antioxidant superoxide dismutase and catalase enzymes in the liver. Furthermore, burdock intervention diminished the size of GST-P+ remodeling preneoplastic lesions (PNLs) and displayed a trend on reducing hepatocyte proliferation (Ki-67) inside them. These findings suggest that short-term exposure to BRE alleviated remodeling PNL development in NASH-associated hepatocarcinogenesis.


Asunto(s)
Antiinflamatorios/uso terapéutico , Antioxidantes/uso terapéutico , Arctium/química , Neoplasias Hepáticas/prevención & control , Enfermedad del Hígado Graso no Alcohólico/tratamiento farmacológico , Extractos Vegetales/uso terapéutico , Lesiones Precancerosas/prevención & control , Animales , Antiinflamatorios/aislamiento & purificación , Antioxidantes/aislamiento & purificación , Antioxidantes/metabolismo , Ácidos Cafeicos , Dieta Alta en Grasa/efectos adversos , Humanos , Neoplasias Hepáticas/patología , Masculino , Medicina Tradicional China , Enfermedad del Hígado Graso no Alcohólico/patología , Extractos Vegetales/aislamiento & purificación , Raíces de Plantas/química , Lesiones Precancerosas/patología , Ratas , Ratas Wistar , Tioacetamida/toxicidad
4.
Artículo en Inglés | MEDLINE | ID: mdl-31585636

RESUMEN

Red and processed meat consumption has been strongly related to increase the risk of colorectal cancer (CRC), although its impact is largely unknown. Hemin, an iron-containing porphyrin, is acknowledged as a putative factor of red and processed meat pro-carcinogenic effects. The aim of this study was to investigate the effects of high dietary hemin on the promotion/progression stages of 1,2-dimethylhydrazine (1,2-DMH)-induced colon carcinogenesis. Twenty-four Wistar male rats were given four subcutaneous 1,2-DMH injections and received either balanced diet or balanced diet supplemented with hemin 0.5 mmol/kg for 23 weeks. Colon specimens were analyzed for aberrant crypt foci (ACF) and tumor development. Dietary hemin significantly increased ACF number and fecal water cytotoxicity/genotoxicity in Caco-2 cells when compared to 1,2-DMH control group. However, tumor incidence, multiplicity and cell proliferation did not differ between 1,2-DMH + hemin and 1,2-DMH control group. Gene expression analysis of 91 target-genes revealed that only three genes (Figf, Pik3r5 and Tgfbr2) were down-regulated in the tumors from hemin-fed rats compared to those from 1,2-DMH control group. Therefore, the findings of this study show that high hemin intake promotes mainly DNA damage and ACF development and but does not change the number nor incidence of colon tumors induced by 1,2-DMH in male rats.


Asunto(s)
Focos de Criptas Aberrantes/inducido químicamente , Neoplasias del Colon/inducido químicamente , Daño del ADN , Hemina/toxicidad , Lesiones Precancerosas/inducido químicamente , 1,2-Dimetilhidrazina , Alimentación Animal , Animales , Células CACO-2 , Cocarcinogénesis , Ensayo Cometa , Regulación hacia Abajo/efectos de los fármacos , Heces , Humanos , Masculino , Fosfatidilinositol 3-Quinasa/genética , Ratas , Ratas Wistar , Receptor Tipo II de Factor de Crecimiento Transformador beta/biosíntesis , Receptor Tipo II de Factor de Crecimiento Transformador beta/genética , Carne Roja , Factores de Tiempo , Factor D de Crecimiento Endotelial Vascular/biosíntesis , Factor D de Crecimiento Endotelial Vascular/genética
5.
Food Chem Toxicol ; 121: 237-245, 2018 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-30194994

RESUMEN

This study evaluated the possible protective effects of lyophilized açaí pulp (AP) in a colitis-associated carcinogenesis (CAC) rat model and the modifying effect of cyanidin 3-rutinoside (C3R) on the motility of RKO colon adenocarcinoma cells, using the wound healing assay. Male Wistar rats were induced to develop CAC using 1,2-dimethylhydrazine (DMH) and 2,4,6-trinitrobenzene acid (TNBS). Animals were randomly assigned to different groups that received basal diet or basal diet supplemented with 5.0% or 7.5% lyophilized AP. The findings indicate: 1) C3R (25 µM) has the potential to reduce RKO cell motility in vitro; 2) ingestion of lyophilized AP reduces the total number of aberrant crypt foci (ACF), ACF multiplicity, tumor cell proliferation and incidence of tumors with high grade dysplasia; 3) AP increases the gene expression of negative regulators of cell proliferation such as Dlc1 and Akt3, as well as inflammation (Ppara). Thus, lyophilized AP could exert a potential antitumor activity.


Asunto(s)
Antocianinas/farmacología , Movimiento Celular/efectos de los fármacos , Colitis/inducido químicamente , Neoplasias del Colon/etiología , Euterpe/química , Extractos Vegetales/farmacología , Animales , Antocianinas/administración & dosificación , Carotenoides/química , Carotenoides/farmacología , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Colitis/complicaciones , Neoplasias del Colon/prevención & control , Liofilización , Frutas/química , Regulación Neoplásica de la Expresión Génica/efectos de los fármacos , Humanos , Masculino , Extractos Vegetales/química , Ratas , Ratas Wistar
6.
Food Chem Toxicol ; 107(Pt A): 27-36, 2017 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-28634113

RESUMEN

Hexachlorobezene (HCB), a fungicide widely distributed in the environment, promotes the development of hepatocellular preneoplastic lesions (PNL) and tumors in rodents. In contrast, vitamin D3 (VD3) supplementation presents a potential role for the prevention/treatment of chronic liver diseases. Thus, we investigated whether VD3 supplementation attenuates the early stage of HCB-promoted hepatocarcinogenesis. Female Balb/C mice were injected a single dose of diethylnitrosamine (DEN, 50 mg/kg) at postnatal day 15. From day 40 onwards, mice were fed with a standard diet containing 0.02% HCB alone or supplemented with VD3 (10,000 or 20,000 IU/Kg diet) for 20 weeks. Untreated mice were fed just standard diet. After this period, mice were euthanized and liver and serum samples were collected. Compared to the untreated group, DEN/HCB treatment decreased total hepatic glutathione levels and glutathione peroxidase (GSH-Px) activity while increased lipid peroxidation, p65 protein expression, cell proliferation/apoptosis and the PNL development. In contrast, dietary VD3 supplementation enhanced vitamin D receptor (VDR) protein expression, total glutathione levels and GSH-Px activity while diminished lipid hydroperoxide levels. Also, VD3 supplementation decreased p65 protein expression, hepatocyte proliferation, the size and the liver area occupied by PNL. Therefore, our findings indicate that VD3 supplementation attenuates the early stage of HCB-promoted hepatocarcinogenesis.


Asunto(s)
Colecalciferol/administración & dosificación , Suplementos Dietéticos/análisis , Fungicidas Industriales/toxicidad , Hexaclorobenceno/toxicidad , Neoplasias Hepáticas Experimentales/prevención & control , Animales , Apoptosis/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Colecalciferol/análisis , Femenino , Fungicidas Industriales/metabolismo , Glutatión/metabolismo , Hexaclorobenceno/metabolismo , Humanos , Hígado/efectos de los fármacos , Hígado/metabolismo , Neoplasias Hepáticas Experimentales/etiología , Neoplasias Hepáticas Experimentales/metabolismo , Neoplasias Hepáticas Experimentales/patología , Ratones , Ratones Endogámicos BALB C , Estrés Oxidativo/efectos de los fármacos , Receptores de Calcitriol/genética , Receptores de Calcitriol/metabolismo
7.
J Nutr Biochem ; 44: 71-79, 2017 06.
Artículo en Inglés | MEDLINE | ID: mdl-28427009

RESUMEN

Zinc deficiency during pregnancy and postnatal life can adversely increase risk of developing human diseases at adulthood. The present study was designed to evaluate whether dietary zinc deficiency or supplementation during the pregnancy, lactation and juvenile stages interferes in the development of mammary tumors induced by 7,12-dimethylbenzanthracene (DMBA) in female Sprague-Dawley (SD) rats. Pregnant female SD rats were allocated into three groups: zinc-adequate diet (ZnA - 35-mg/kg chow), zinc-deficient diet (ZnD - 3-mg/kg chow) or zinc-supplemented diet (ZnS - 180-mg/kg chow) during gestational day 10 (GD 10) until the litters' weaning. Female offspring received the same diets as their dams until postnatal day (PND) 51. At PND 51, the animals received a single dose of DMBA (50 mg/kg, ig) and zinc-adequate diets. At PND 180, female were euthanized, and tumor samples were processed for histological evaluation and gene expression microarray analysis. The ZnD induced a significant reduction in female offspring body weight evolution and in mammary gland development. At late in life, the ZnD or ZnS did not alter the latency, incidence, multiplicity, volume or histological types of mammary tumors in relation to the ZnA group. However, the total tumor number in ZnS group was higher than in ZnA group, accompanied by distinct expression of 4 genes up- and 15 genes down-regulated. The present findings indicate that early-in-life dietary zinc supplementation, differently to zinc deficiency, has a potential to modify the susceptibility to the development of mammary tumors induced by DMBA.


Asunto(s)
Suplementos Dietéticos , Neoplasias Mamarias Experimentales/patología , Efectos Tardíos de la Exposición Prenatal/sangre , Zinc/administración & dosificación , Zinc/deficiencia , 9,10-Dimetil-1,2-benzantraceno/toxicidad , Animales , Peso Corporal , Dieta , Femenino , Humanos , Masculino , Glándulas Mamarias Humanas/crecimiento & desarrollo , Neoplasias Mamarias Experimentales/inducido químicamente , Embarazo , Ratas , Ratas Sprague-Dawley , Reproducibilidad de los Resultados , Zinc/sangre
8.
Nutrients ; 8(7)2016 Jul 21.
Artículo en Inglés | MEDLINE | ID: mdl-27455312

RESUMEN

Yacon (Smallanthus sonchifolius), a perennial plant of the family Asteraceae native to the Andean regions of South America, is an abundant source of fructooligosaccharides (FOS). This comprehensive review of the literature addressed the role of yacon supplementation in promoting health and reducing the risk of chronic diseases. According to several preclinical and clinical trials, FOS intake favors the growth of health-promoting bacteria while reducing pathogenic bacteria populations. Moreover, the endproducts of FOS fermentation by the intestinal microbiota, short chain fatty acids (SCFA), act as substrates or signaling molecules in the regulation of the immune response, glucose homeostasis and lipid metabolism. As a result, glycemic levels, body weight and colon cancer risk can be reduced. Based on these findings, most studies reviewed concluded that due to their functional properties, yacon roots may be effectively used as a dietary supplement to prevent and treat chronic diseases.


Asunto(s)
Asteraceae/química , Enfermedad Crónica/prevención & control , Disbiosis/prevención & control , Alimentos Funcionales , Oligosacáridos/uso terapéutico , Tubérculos de la Planta/química , Prebióticos , Animales , Enfermedad Crónica/epidemiología , Disbiosis/inmunología , Disbiosis/microbiología , Disbiosis/fisiopatología , Fermentación , Manipulación de Alimentos , Alimentos Funcionales/efectos adversos , Alimentos Funcionales/análisis , Microbioma Gastrointestinal/inmunología , Humanos , Oligosacáridos/análisis , Oligosacáridos/metabolismo , Extractos Vegetales/efectos adversos , Extractos Vegetales/química , Extractos Vegetales/uso terapéutico , Prebióticos/efectos adversos , Prebióticos/análisis , Factores de Riesgo
9.
Int J Cancer ; 139(8): 1873-82, 2016 10 15.
Artículo en Inglés | MEDLINE | ID: mdl-27270969

RESUMEN

Breast cancer is a global public health problem and accumulating evidence indicates early-life exposures as relevant factors in the disease risk determination. Recent studies have shown that paternal nutrition can influence offspring health including breast cancer risk. Selenium is a micronutrient with essential role in central aspects of embryogenesis, male fertility and cancer and that has been extensively studied as a chemopreventive agent in several breast cancer experimental models. Thus, we designed an animal study to evaluate whether paternal selenium deficiency or supplementation during preconception could affect the female offspring mammary gland development and breast cancer susceptibility. Male Sprague-Dawley rats were fed AIN93-G diet containing 0.15 ppm (control diet), 0.05 ppm (deficient diet) or 1 ppm (supplemented diet) of selenium for 9 weeks and mated with control female rats. Mammary carcinogenesis was induced with 7,12-dimethylbenz[a]anthracene (DMBA) in their female offspring. Paternal selenium deficiency increased the number of terminal end buds, epithelial elongation and cell proliferation in the mammary gland of the female rat offspring and these effects were associated with higher susceptibility to DMBA-induced mammary tumors (increased incidence and higher grade tumors). On the other hand, paternal selenium supplementation did not influence any of these parameters. These results highlight the importance of father's nutrition including selenium status as a relevant factor affecting daughter's breast cancer risk and paternal preconception as a potential developmental stage to start disease preventive strategies.


Asunto(s)
Neoplasias Mamarias Experimentales/etiología , Selenio/administración & dosificación , Selenio/deficiencia , 9,10-Dimetil-1,2-benzantraceno , Animales , Carcinogénesis , Suplementos Dietéticos , Femenino , Masculino , Glándulas Mamarias Animales/crecimiento & desarrollo , Glándulas Mamarias Animales/patología , Neoplasias Mamarias Experimentales/inducido químicamente , Neoplasias Mamarias Experimentales/patología , Ratas , Ratas Sprague-Dawley
10.
Food Chem Toxicol ; 64: 20-6, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24275088

RESUMEN

Coffee has been inversely related to the incidence of human liver disease; however, whether caffeine is the component responsible for the beneficial effects of coffee remains controversial. This study evaluated the beneficial effects of coffee or caffeine in a medium-term bioassay for rat liver fibrosis/carcinogenesis induced by diethylnitrosamine (DEN) and carbon tetrachloride (CCl4). One week after the DEN injection, the groups started to receive conventional coffee, instant coffee or 0.1% caffeine ad libitum for 24 weeks. The groups receiving conventional coffee or caffeine presented a significant reduction in collagen content and mRNA expression of collagen I. The groups receiving instant coffee or caffeine had a significant reduction in the size and area of pre-neoplastic lesions and in the mean number of neoplastic lesions. A significant increase in liver bax protein levels was observed in the groups receiving instant coffee or caffeine as compared to the control group. These data indicate that the most pronounced hepatoprotective effect against fibrosis was observed in the groups receiving conventional coffee and 0.1% caffeine, and the greatest effects against liver carcinogenesis were detected in the groups receiving instant coffee and 0.1% caffeine.


Asunto(s)
Cafeína/farmacología , Carcinogénesis/efectos de los fármacos , Café , Cirrosis Hepática/prevención & control , Neoplasias Hepáticas Experimentales/prevención & control , Animales , Western Blotting , Colágeno/metabolismo , Glutatión Transferasa/metabolismo , Neoplasias Hepáticas Experimentales/enzimología , Masculino , Lesiones Precancerosas/enzimología , Lesiones Precancerosas/metabolismo , Ratas , Ratas Wistar , Reacción en Cadena en Tiempo Real de la Polimerasa
11.
Plant Foods Hum Nutr ; 67(3): 235-41, 2012 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-22961050

RESUMEN

Açai, fruit from Euterpe oleraceae Martius, is consumed in natura and in a variety of beverages and food preparations and possesses several potential antioxidant compounds. In a first study for anticarcinogenicity screening, male Swiss mice (n = 20/per group) were chemically-induced to urothelial bladder carcinogenesis for 10 weeks and received a standard diet or a standard diet containing 2.5 and 5 % spray-dried açai pulp (AP) for 10 weeks. At week 20, the incidence of simple and nodular hyperplasia and the incidence and multiplicity of transitional cell carcinoma (TCC) were evaluated. In a second study for antigenotoxicity screening, male Swiss mice (n = 6/per group) were fed standard diet or standard diet containing 5 % AP for three weeks. Urothelial cell suspensions were obtained and challenged with H(2)O(2) for induction of DNA damage and analyzed by comet assay. Overall, dietary 5 % AP reduced TCC incidence and multiplicity (p = 0.019 and p = 0.015, respectively) and tumor cell proliferation and p63 expression (p = 0.02 and p = 0.007, respectively), Furthermore, the group fed the 5 % AP presented a significant reduction (p < 0.01) in DNA damage induced by H(2)O(2), a notable oxidant agent. The results suggest that the spray-dried açai pulp used here inhibits the TCC development in male Swiss mice, probably due to its potential antioxidant action.


Asunto(s)
Arecaceae , Carcinoma de Células Transicionales/prevención & control , Dieta , Frutas , Fitoterapia , Neoplasias de la Vejiga Urinaria/prevención & control , Vejiga Urinaria/efectos de los fármacos , Animales , Anticarcinógenos/farmacología , Anticarcinógenos/uso terapéutico , Antineoplásicos Fitogénicos/farmacología , Antineoplásicos Fitogénicos/uso terapéutico , Antioxidantes/farmacología , Antioxidantes/uso terapéutico , Carcinoma de Células Transicionales/metabolismo , Proliferación Celular/efectos de los fármacos , Ensayo Cometa , Daño del ADN/efectos de los fármacos , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Peróxido de Hidrógeno , Hiperplasia , Masculino , Ratones , Ratones Endogámicos , Fosfoproteínas/metabolismo , Preparaciones de Plantas/farmacología , Preparaciones de Plantas/uso terapéutico , Transactivadores/metabolismo , Vejiga Urinaria/citología , Vejiga Urinaria/metabolismo , Neoplasias de la Vejiga Urinaria/inducido químicamente , Neoplasias de la Vejiga Urinaria/metabolismo
12.
Basic Clin Pharmacol Toxicol ; 111(5): 339-47, 2012 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-22646289

RESUMEN

Coffee intake has been inversely related to the incidence of liver diseases, although there are controversies on whether these beneficial effects on human health are because of caffeine or other specific components in this popular beverage. Thus, this study evaluated the protective effects of coffee or caffeine intake on liver injury induced by repeated thioacetamide (TAA) administration in male Wistar rats. Rats were randomized into five groups: one untreated group (G1) and four groups (G2-G5) treated with the hepatotoxicant TAA (200 mg/kg b.w., i.p.) twice a week for 8 weeks. Concomitantly, rats received tap water (G1 and G2), conventional coffee (G3), decaffeinated coffee (G4) or 0.1% caffeine (G5). After 8 weeks of treatment, rats were killed and blood and liver samples were collected. Conventional and decaffeinated coffee and caffeine intake significantly reduced serum levels of alanine aminotransferase (ALT) (p < 0.001) and oxidized glutathione (p < 0.05), fibrosis/inflammation scores (p < 0.001), collagen volume fraction (p < 0.01) and transforming growth factor ß-1 (TGF-ß1) protein expression (p ≤ 0.001) in the liver from TAA-treated groups. In addition, conventional coffee and caffeine intake significantly reduced proliferating cellular nuclear antigen (PCNA) S-phase indexes (p < 0.001), but only conventional coffee reduced cleaved caspase-3 indexes (p < 0.001), active metalloproteinase 2 (p ≤ 0.004) and the number of glutathione S-transferase placental form (GST-P)-positive preneoplastic lesions (p < 0.05) in the liver from TAA-treated groups. In conclusion, conventional coffee and 0.1% caffeine intake presented better beneficial effects than decaffeinated coffee against liver injury induced by TAA in male Wistar rats.


Asunto(s)
Cafeína/uso terapéutico , Enfermedad Hepática Inducida por Sustancias y Drogas/prevención & control , Café/química , Hígado/efectos de los fármacos , Tioacetamida/antagonistas & inhibidores , Animales , Cafeína/administración & dosificación , Caspasa 3/metabolismo , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Enfermedad Hepática Inducida por Sustancias y Drogas/fisiopatología , Colágeno/metabolismo , Manipulación de Alimentos , Glutatión/metabolismo , Hígado/metabolismo , Hígado/patología , Hígado/fisiopatología , Cirrosis Hepática/etiología , Cirrosis Hepática/prevención & control , Masculino , Metaloproteinasa 2 de la Matriz/metabolismo , Oxidación-Reducción , Lesiones Precancerosas/etiología , Lesiones Precancerosas/prevención & control , Antígeno Nuclear de Célula en Proliferación/metabolismo , Distribución Aleatoria , Ratas , Ratas Wistar , Tioacetamida/toxicidad , Factor de Crecimiento Transformador beta1/metabolismo
13.
Basic Clin Pharmacol Toxicol ; 111(2): 92-8, 2012 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-22380924

RESUMEN

The noxious effects of dietary zinc deficiency (ZD) and deoxycholic bile acid (DCA) supplementation in the oesophagus were investigated. The additional influence of cigarette smoke and ethanol intake on the changes in the oesophageal mucosa induced by dietary ZD plus DCA was also assessed. Male C57BL/6 mice were allocated into four groups: Group 1 was fed control diet and groups 2-4 were fed ZD plus DCA diet. After 5 weeks, groups 3 and 4 were exposed to 10% ethanol intake or cigarette smoke for 15 weeks, respectively. All animals were euthanized at the end of week 20, and the oesophagus, lung, liver and colon were collected and analysed by conventional morphology. Cell proliferation was assessed in the oesophageal mucosa by Ki-67 immunohistochemistry and cyclooxygenase 2 (COX-2) protein by Western blotting. Dietary ZD plus DCA treatment induced mild hyperkeratosis and hyperplasia, increased cell proliferation index and COX-2 protein expression in the oesophagus, and intranuclear inclusion, karyocytomegaly and microvesicular fatty change in the liver. Cigarette smoke increased COX-2 protein expression in oesophageal mucosa and irregular enlargement of alveolus and alveolar ductal air spaces, while ethanol enhanced liver damage induced by ZD plus DCA diet. These findings indicate that dietary ZD plus DCA treatment during 20 weeks induces a pattern of chemical oesophageal injury but not Barrett's-like lesions.


Asunto(s)
Ácido Desoxicólico/administración & dosificación , Suplementos Dietéticos/efectos adversos , Esófago/patología , Etanol/efectos adversos , Humo/efectos adversos , Zinc/deficiencia , Animales , Western Blotting , Proliferación Celular/efectos de los fármacos , Ciclooxigenasa 2/genética , Ciclooxigenasa 2/metabolismo , Ácido Desoxicólico/efectos adversos , Dieta , Esófago/efectos de los fármacos , Inmunohistoquímica , Hígado/efectos de los fármacos , Hígado/patología , Hepatopatías Alcohólicas/etiología , Hepatopatías Alcohólicas/patología , Masculino , Ratones , Ratones Endogámicos C57BL , Membrana Mucosa/efectos de los fármacos , Membrana Mucosa/patología , Nicotiana/efectos adversos , Zinc/administración & dosificación , Zinc/efectos adversos
14.
J Med Food ; 15(2): 161-8, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22082069

RESUMEN

Lemongrass (Cymbopogon citratus Stapf) essential oil has been used worldwide because of its ethnobotanical and medicinal usefulness. Regarding its medicinal usefulness, the present study evaluated the beneficial effects of lemongrass essential oil (LGEO) oral treatment on cell proliferation and apoptosis events and on early development of hyperplastic lesions in the mammary gland, colon, and urinary bladder induced by N-methyl-N-nitrosourea (MNU) in female BALB/c mice. The animals were allocated into three groups: G1, treated with LGEO vehicle for 5 weeks (five times per week); G2, treated with LGEO vehicle as for G1 and MNU (two injections each of 30 mg/kg of body weight at weeks 3 and 5); and G3, treated with LGEO (five times each with 500 mg/kg of body weight per week) and MNU as for G2. Twenty-four hours after the last MNU application, all animals were euthanized, and mammary glands, colon, and urinary bladder were collected for histological and immunohistochemical analysis. LGEO oral treatment significantly changed the indexes of apoptosis and/or cellular proliferation for the tissues analyzed. In particular, the treatment reduced the incidence of hyperplastic lesions and increased apoptosis in mammary epithelial cells. This increment in the apoptosis response may be related to a favorable balance in Bcl-2/Bax immunoreactivity in mammary epithelial cells. These findings indicate that LGEO presented a protective role against early MNU-induced mammary gland alterations in BALB/c mice.


Asunto(s)
Carcinógenos/toxicidad , Cymbopogon/química , Metilnitrosourea/toxicidad , Neoplasias/tratamiento farmacológico , Aceites de Plantas/farmacología , Terpenos/farmacología , Animales , Apoptosis/efectos de los fármacos , Ciclo Celular/efectos de los fármacos , Femenino , Humanos , Ratones , Neoplasias/inducido químicamente , Neoplasias/fisiopatología , Especificidad de Órganos/efectos de los fármacos
15.
Food Chem Toxicol ; 49(9): 2268-72, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21693164

RESUMEN

Cymbopogon citratus (lemongrass) is currently used in traditional folk medicine. Although this species presents widespread use, there are no scientific data on its efficacy or safety after repeated treatments. Therefore, this work investigated the toxicity and genotoxicity of this lemongrass's essential oil (EO) in male Swiss mice. The single LD(50) based on a 24h acute oral toxicity study was found to be around 3500 mg/kg. In a repeated-dose 21-day oral toxicity study, mice were randomly assigned to two control groups, saline- or Tween 80 0.01%-treated groups, or one of the three experimental groups receiving lemongrass EO (1, 10 or 100mg/kg). No significant changes in gross pathology, body weight, absolute or relative organ weights, histology (brain, heart, kidneys, liver, lungs, stomach, spleen and urinary bladder), urinalysis or clinical biochemistry were observed in EO-treated mice relative to the control groups. Additionally, blood cholesterol was reduced after EO-treatment at the highest dose tested. Similarly, data from the comet assay in peripheral blood cells showed no genotoxic effect from the EO. In conclusion, our findings verified the safety of lemongrass intake at the doses used in folk medicine and indicated the beneficial effect of reducing the blood cholesterol level.


Asunto(s)
Colesterol/metabolismo , Cymbopogon/química , Aceites Volátiles/toxicidad , Animales , Peso Corporal/efectos de los fármacos , Ensayo Cometa , Dosificación Letal Mediana , Masculino , Ratones , Aceites Volátiles/administración & dosificación , Tamaño de los Órganos/efectos de los fármacos
16.
J Appl Toxicol ; 31(6): 536-44, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21089157

RESUMEN

This study investigated the protective effect of oral treatment with lemongrass (Cymbopogon citratus STAPF) essential oil (LGEO) on leukocyte DNA damage induced by N-methyl-N-nitrosurea (MNU). Also, the anticarcinogenic activity of LGEO was investigated in a multi-organ carcinogenesis bioassay induced by 7,12-dimethylbenz(a)antracene, 1,2-dimethylhydrazine and N-butyl-N-(4-hydroxibuthyl)nitrosamine in Balb/C female Balb/c mice (DDB-initiated mice). In the short-term study, the animals were allocated into three groups: vehicle group (negative control), MNU group (positive control) and LGEO 500 mg kg⁻¹ (five times per week for 5 weeks) plus MNU group (test group). Blood samples were collected to analyze leukocyte DNA damage by comet assay 4 h after each MNU application at the end of weeks 3 and 5. The LGEO 500 mg kg⁻¹ treated group showed significantly lower (P < 0.01) leukocyte DNA damage than its respective positive group exposed to MNU alone at week 3. In the medium-term study, DDB-initiated mice were allocated into three groups: vehicle group (positive control) and LGEO 125 or 500 mg kg⁻¹ (five times per week for 6 weeks; test groups). At week 20, all animals were euthanized and mammary glands, colon and urinary bladder were processed for histopathological analyses for detection of preneoplastic and neoplastic lesions. A slight non-significant effect of treatment with LGEO 500 mg kg⁻¹ in reducing development of alveolar and ductal mammary hyperplasia was found (P = 0.075). Our findings indicate that lemongrass essential oil provided protective action against MNU-induced DNA damage and a potential anticarcinogenic activity against mammary carcinogenesis in DDB-initiated female Balb/C mice.


Asunto(s)
Carcinogénesis/efectos de los fármacos , Carcinógenos/toxicidad , Daño del ADN/efectos de los fármacos , Aceites de Plantas/farmacología , Terpenos/farmacología , Animales , Pruebas de Carcinogenicidad , Colon/efectos de los fármacos , Colon/metabolismo , Ensayo Cometa , Determinación de Punto Final , Femenino , Cromatografía de Gases y Espectrometría de Masas , Glándulas Mamarias Animales/efectos de los fármacos , Glándulas Mamarias Animales/metabolismo , Metilnitrosourea/toxicidad , Ratones , Ratones Endogámicos BALB C , Vejiga Urinaria/efectos de los fármacos , Vejiga Urinaria/patología
17.
Exp Toxicol Pathol ; 60(1): 59-68, 2008 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-18434113

RESUMEN

Various studies have shown that lycopene, a non-provitamin A carotenoid, exerts antioxidant, antimutagenic and anticarcinogenic activities in different in vitro and in vivo systems. However, the results concerning its chemopreventive potential on rat hepatocarcinogenesis are ambiguous. The aim of the present study was to investigate the antigenotoxic and anticarcinogenic effects of dietary tomato oleoresin adjusted to lycopene concentration at 30, 100 or 300 ppm (administered 2 weeks before and during or 8 weeks after carcinogen exposure) on liver of male Wistar rats treated with a single intraperitoneal dose of 20 or 100mg/kg of diethylnitrosamine (DEN), respectively. The level of DNA damage in liver cells and the development of putative preneoplastic single hepatocytes, minifoci and foci of altered hepatocytes (FHA) positive for glutathione S-transferase (GST-P) were used as endpoints. Significant reduction of DNA damage was detected when the highest lycopene concentration was administered before and during the DEN exposure (20mg/kg). However, the results also showed that lycopene consumption did not reduce cell proliferation in normal hepatocytes or the growth of initiated hepatocytes into minifoci positive for GST-P during early regenerative response after 70% partial hepatectomy, or the number and area of GST-P positive FHA induced by DEN (100mg/kg) at the end of week 10. Taken together, the data suggest a chemopreventive effect of tomato oleoresin against DNA damage induced by DEN but no clear effectiveness in initiating or promoting phases of rat hepatocarcinogenesis.


Asunto(s)
Anticarcinógenos/farmacología , Daño del ADN/efectos de los fármacos , Neoplasias Hepáticas Experimentales/prevención & control , Extractos Vegetales/farmacología , Solanum lycopersicum/química , Animales , Biomarcadores de Tumor/metabolismo , Carcinógenos/toxicidad , Proliferación Celular/efectos de los fármacos , Quimioprevención , Ensayo Cometa , Dietilnitrosamina/toxicidad , Relación Dosis-Respuesta a Droga , Glutatión Transferasa/biosíntesis , Glutatión Transferasa/efectos de los fármacos , Hepatocitos/efectos de los fármacos , Hepatocitos/patología , Hígado/efectos de los fármacos , Hígado/metabolismo , Hígado/patología , Neoplasias Hepáticas Experimentales/inducido químicamente , Neoplasias Hepáticas Experimentales/patología , Masculino , Lesiones Precancerosas/tratamiento farmacológico , Lesiones Precancerosas/enzimología , Lesiones Precancerosas/patología , Antígeno Nuclear de Célula en Proliferación/metabolismo , Ratas , Ratas Wistar
18.
Chem Biol Interact ; 173(1): 32-42, 2008 May 09.
Artículo en Inglés | MEDLINE | ID: mdl-18367157

RESUMEN

Ginkgo biloba (EGb) has been proposed as a promising candidate for cancer chemoprevention and has shown protective effects on the liver against chemically induced oxidative injury and fibrosis. The potential beneficial effects of EGb were investigated in two rat liver carcinogenesis bioassays induced by diethylnitrosamine (DEN). In a short-term study for anti-initiating screening, male Wistar rats were fed a basal diet or supplemented diet with 500 or 1000 ppm EGb and initiated 14 days later with a single dose of DEN (100 mg/kg i.p.). The respective groups were killed 24h or 2 weeks after DEN-initiation. Liver samples were collected for the analysis of proliferating cell nuclear antigen (PCNA), transforming growth factor alpha (TGF-alpha), p53, apoptosis and induction of single hepatocytes and minifoci positive for the enzyme glutathione S-transferase P-form (GST-P). In a medium-term study for anti-promoting screening, the animals received a single dose of DEN (200 mg/kg i.p.) and, 2 weeks later, were fed a basal diet or supplemented diet with 500 or 1000 ppm EGb for 6 weeks. All animals underwent 70% partial hepatectomy (PH) at week 3 and killed at week 8. Liver samples were collected to analyze development of preneoplastic foci of altered hepatocytes (FAH) expressing GST-P. In the short-term study, pretreatment of rats with 1000 ppm EGb significantly reduced the rates of cell proliferation, apoptosis and p53, TGF-alpha immunoreactivity and the number of GST-P-positive hepatocytes. In the medium-term study, EGb treatment during the post-initiation stage failed to reduce the development of DEN-induced GST-P-positive foci. Thus, EGb presented inhibitory actions during initiation but not promotion of rat liver carcinogenesis induced by DEN.


Asunto(s)
Ginkgo biloba/química , Neoplasias Hepáticas Experimentales/prevención & control , Extractos Vegetales/administración & dosificación , Animales , Bioensayo , Carcinógenos/toxicidad , Dietilnitrosamina/toxicidad , Glutatión/metabolismo , Neoplasias Hepáticas Experimentales/inducido químicamente , Masculino , Antígeno Nuclear de Célula en Proliferación/metabolismo , Ratas , Ratas Wistar , Factor de Crecimiento Transformador alfa/metabolismo , Proteína p53 Supresora de Tumor/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA